Trial intelligence / Profile preview

Compound Congrong Yizhi Capsule for mild cognitive impairment

ChiCTR-TRC-12003073Phase 2Completed

Sponsor
Beijing University of Chinese Medicine East Hospital
Start
Nov 2012
Countries
1
01

Overview

Phase 2 trial of fufang congrong yizhi in Mild Cognitive Impairment (MCI) (2 arms), sponsored by Beijing University of Chinese Medicine East Hospital. Primary endpoint: Mini-Mental State Examination. Started Nov 2012; status: completed.

02

Drugs

fufang congrong yizhi
03

Conditions

Mild Cognitive Impairment (MCI)

Beyond the preview

Go deeper on ChiCTR-TRC-12003073.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-TRC-12003073.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call